Go Pro
→ Buy this stock today (From Chaikin Analytics) (Ad)tc pixel Free HEMO Stock Alerts

Hemogenyx Pharmaceuticals (HEMO) Stock Chart & Stock Price History

Hemogenyx Pharmaceuticals logo
GBX 771 -14.00 (-1.78%)
As of 04:34 AM Eastern
Compare

Hemogenyx Pharmaceuticals Stock Price Performance

The Hemogenyx Pharmaceuticals (HEMO) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 477.53%, with a year-to-date return of 33.39%. In the past month, the stock has decreased 0.90%, reflecting recent market activity.

As of the latest close, Hemogenyx Pharmaceuticals traded at GBX 785 with a market cap of £53.38 million and volume of 5,690 shares. Five years ago, the stock traded at GBX 2.04, representing a 37,694.12% increase over that period. At the time, it had a market cap of £19.99 million and a volume of 13.48 million shares.

Receive HEMO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hemogenyx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-0.52%
1 Month
Performance
-0.90%
3 Month
Performance
-14.33%
Year-To-Date
Performance
+33.39%
1 Year
Performance
+477.53%
5 Year
Performance
+37,694.12%

HEMO Stock Chart for Friday, July, 17, 2026

HEMO Chart by TradingView

Hemogenyx Pharmaceuticals Stock Price History

Export
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
07/16/2026GBX 774GBX 785
+1.42%		GBX 810GBX 7315,690 shs£53.38 million
07/15/2026GBX 766GBX 774
+1.04%		GBX 810GBX 7314,360 shs£52.63 million
07/14/2026GBX 770GBX 766
-0.52%		GBX 816GBX 7316,174 shs£52.09 million
07/13/2026GBX 775GBX 770
-0.65%		GBX 820GBX 7468,106 shs£52.36 million
07/10/2026GBX 775GBX 775GBX 820GBX 7317,680 shs£52.70 million
07/09/2026GBX 775GBX 775GBX 820GBX 731.16418 shs£52.70 million
07/08/2026GBX 790GBX 775
-1.90%		GBX 820GBX 7212,979 shs£52.70 million
07/07/2026GBX 797GBX 790
-0.88%		GBX 820GBX 72016,734 shs£53.72 million
07/06/2026GBX 770GBX 797
+3.51%		GBX 815GBX 711.3010,303 shs£54.20 million
07/03/2026GBX 750GBX 770
+2.67%		GBX 800GBX 75013,174 shs£52.36 million
07/02/2026GBX 752.50GBX 750
-0.33%		GBX 779GBX 7349,378 shs£51 million
07/01/2026GBX 780GBX 752.50
-3.53%		GBX 784.41GBX 735.157,348 shs£51.27 million
06/30/2026GBX 779GBX 780
+0.13%		GBX 789GBX 7208,052 shs£53.04 million
06/29/2026GBX 761GBX 779
+2.37%		GBX 800GBX 7465,178 shs£52.97 million
06/26/2026GBX 739GBX 761
+2.98%		GBX 799GBX 73110,371 shs£51.75 million
06/25/2026GBX 796.11GBX 739
-7.17%		GBX 809GBX 7393,470 shs£50.25 million
06/24/2026GBX 807.66GBX 796.11
-1.43%		GBX 825GBX 78512,867 shs£54.14 million
06/23/2026GBX 810GBX 807.66
-0.29%		GBX 829GBX 785.1013,570 shs£54.92 million
06/22/2026GBX 819GBX 810
-1.10%		GBX 849GBX 80023,556 shs£55.08 million
06/19/2026GBX 797GBX 819
+2.76%		GBX 838GBX 770.7523,954 shs£55.69 million
06/18/2026GBX 778GBX 797
+2.44%		GBX 810GBX 7355,350 shs£54.20 million
06/17/2026GBX 775GBX 778
+0.39%		GBX 778GBX 740.504,854 shs£52.90 million
06/16/2026GBX 740GBX 775
+4.73%		GBX 827GBX 71221,154 shs£52.70 million
Related Companies

This page (LON:HEMO) was last updated on 7/17/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel